Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Robinhood Markets, Inc. (HOOD) vs Inovio Pharmaceuticals Inc (INO) Price & Performance

Robinhood Markets, Inc.Trade
Inovio Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Robinhood Markets, Inc. vs Inovio Pharmaceuticals Inc — how do they compare? Robinhood Markets, Inc. trades at $106.73 (market cap $89.13B), while Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M). The key difference: Robinhood Markets, Inc. is far larger — about 998.4× Inovio Pharmaceuticals Inc's market cap, and Robinhood Markets, Inc. is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.

HOODINO
Market Cap
$89.13B$89.27M
Sector
TechnologyHealth
52-Week High
$152.46$2.87
52-Week Low
$65.16$1.05
Enterprise Value
$90.33B$60.28M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Robinhood Markets, Inc.

Robinhood Markets (HOOD) trades at $106.36, up 6.4% over 24 hours, with technical indicators showing a bearish trend near resistance at $106. The company reported strong 2025 results with $4.47B revenue and $1.88B net income, though Q1 2026 EPS missed expectations. Recent news highlights expansion into blockchain infrastructure and institutional stake changes.

Outlook remains mixed: analyst consensus is bullish with a $118.07 price target, but risks include earnings volatility and competitive pressures. The stock's high P/E of 48.19 suggests premium valuation, requiring sustained growth to justify current levels amid bearish technical signals.

Inovio Pharmaceuticals Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Robinhood Markets, Inc.

Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.

Read more on HOOD

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Read more on INO